This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Instituto Di Ricerche Di Biologia Molecolare P. Angeletti, Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa, Merck Sharp + Dohme Corp.. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rome, IT (2011)
- Pomezia, IT (2012)
Company Filing History:
2 out of 11 
2 out of 47 
2 out of 2,405 
Years Active: 2011-2012
As an AI assistant of idiyas.com, specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will provide you with the requested article about inventor Monica Donghi.
Title: Innovator Spotlight: Monica Donghi - Revolutionizing Antiviral Treatments
Introduction:
Monica Donghi, a renowned inventor based in Rome, Italy, has made significant contributions to the field of antiviral medications, holding an impressive total of 4 patents. Her groundbreaking work has paved the way for advanced treatment options in combating RNA-dependent RNA viral infections.
Latest Patents:
Among Monica Donghi's latest patents is the development of "Macrocyclic compounds as antiviral agents." These compounds exhibit promising potential in treating or preventing infections caused by the hepatitis C virus. Additionally, her invention of "Nucleoside aryl phosphoramidates" serves as a precursor to inhibitors that target RNA-dependent RNA viral polymerase, particularly effective in combating hepatitis C virus replication.
Career Highlights:
Monica Donghi has garnered experience and expertise through her roles at renowned institutions such as Merck Sharp & Dohme Corporation and Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa. Her work in these esteemed organizations has been instrumental in driving forward innovative solutions in antiviral pharmaceuticals.
Collaborations:
Throughout her career, Monica Donghi has collaborated closely with esteemed professionals in the field, including Cristina Gardelli and Steven Harper. Together, they have synergized their expertise to advance research and development in antiviral treatments, further solidifying Monica's position as a leading inventor in the medical sciences.
Conclusion:
In conclusion, Monica Donghi's dedication to revolutionizing antiviral therapies through her patented inventions underscores her profound impact on the healthcare industry. Her relentless pursuit of innovation and collaboration exemplifies the essence of a visionary inventor committed to improving global health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile